P. Wingrove

发表

Cloning and expression of a cDNA encoding the human GABA-A receptor alpha 5 subunit.

J. Kemp, P. Whiting, C. Ragan, 1992, Biochemical Society transactions.

Role of the histidine residue at position 105 in the human α5 containing GABAA receptor on the affinity and efficacy of benzodiazepine site ligands

M. D. Kelly, J. Atack, K. Maubach, 2002, British journal of pharmacology.

A genetically modified mouse model probing the selective action of ifenprodil at the N-methyl-d-aspartate type 2B receptor

P. Whiting, R. Heavens, T. Rosahl, 2006, Molecular and Cellular Neuroscience.

The non‐peptidyl fungal metabolite L‐783,281 activates TRK neurotrophin receptors

J. Bilsland, L. Young, S. Harper, 2001, Journal of neurochemistry.

Mechanism of α-subunit selectivity of benzodiazepine pharmacology at γ-aminobutyric acid type A receptors

P. Whiting, P. Safo, S. Thompson, 2002 .

Mechanism of alpha-subunit selectivity of benzodiazepine pharmacology at gamma-aminobutyric acid type A receptors.

P. Whiting, P. Safo, S. Thompson, 2002, European journal of pharmacology.

FISH ordering of reference markers and of the gene for the α5 subunit of the γ-aminobutyric acid receptor (GABRA5) within the Angelman and Prader–Willi syndrome chromosomal regions

J. Sikela, D. Sinnett, K. Glatt, 1993 .

FISH ordering of reference markers and of the gene for the alpha 5 subunit of the gamma-aminobutyric acid receptor (GABRA5) within the Angelman and Prader-Willi syndrome chromosomal regions.

J. Sikela, D. Sinnett, K. Glatt, 1993, Human molecular genetics.

Tracazolate Reveals a Novel Type of Allosteric Interaction with Recombinant γ-Aminobutyric AcidA Receptors

P. Whiting, K. Wafford, Keith A. Wafford, 2002 .

Residues in transmembrane domains I and II determine gamma-aminobutyric acid type AA receptor subtype-selective antagonism by furosemide.

P. Whiting, K. Wafford, G. Marshall, 1999, Molecular pharmacology.

Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors.

J. Sikela, J. Kemp, C. Ragan, 1993, Molecular pharmacology.

Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors.

P. Whiting, C. Ragan, P J Whiting, 1993, Molecular pharmacology.

The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit.

P. Whiting, K. Wafford, C. Bain, 1994, Proceedings of the National Academy of Sciences of the United States of America.

A novel allosteric modulatory site on the GABAA receptor β subunit

J. Kemp, R. Mckernan, P. Whiting, 1994, Neuron.

Salicylidene salicylhydrazide, a selective inhibitor of β1‐containing GABAA receptors

C. Adkins, I. Collins, P. Whiting, 2004, British journal of pharmacology.

Identification of amino acid residues responsible for the α5 subunit binding selectivity of L‐655,708, a benzodiazepine binding site ligand at the GABAA receptor

P. Whiting, K. Maubach, G. Seabrook, 2001 .

Key Amino Acids in the γ Subunit of the γ-Aminobutyric AcidA Receptor that Determine Ligand Binding and Modulation at the Benzodiazepine Site

P. Whiting, K. Wafford, P. Wingrove, 1997 .

The modulatory action of loreclezole at the y-aminobutyric acid type A receptor is determined by a single amino acid in the P 2 and f 3 subunit

P. Whiting, K. Wafford, C. Bain, 2004 .

beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site.

P. Whiting, K. Wafford, P. Wingrove, 1995, Molecular pharmacology.

A novel allosteric modulatory site on the GABAA receptor beta subunit.

J. Kemp, R. Mckernan, P. Whiting, 1994, Neuron.

Pharmacology of GABA(A) receptors exhibiting different levels of spontaneous activity.

K. Wafford, M. Mortensen, B. Ebert, 2003, European journal of pharmacology.

Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABA(A) receptor.

P. Whiting, K. Maubach, G. Seabrook, 2001, Journal of neurochemistry.

Characterisation of N‐Methyl‐D‐Aspartate Receptor‐Specific [3H]Ifenprodil Binding to Recombinant Human NR1a/NR2B Receptors Compared with Native Receptors in Rodent Brain Membranes

S. Grimwood, F. Murray, P. Hutson, 2000, Journal of neurochemistry.

Mutation at the putative GABAA ion‐channel gate reveals changes in allosteric modulation

P. Whiting, K. Wafford, P. Wingrove, 1999, British journal of pharmacology.

Generation and Characterisation of Stable Cell Lines Expressing Recombinant Human N‐Methyl‐d‐Aspartate Receptor Subtypes

R. Mckernan, P. Whiting, J. Atack, 1996, Journal of neurochemistry.

Key amino acids in the gamma subunit of the gamma-aminobutyric acidA receptor that determine ligand binding and modulation at the benzodiazepine site.

P. Whiting, K. Wafford, P. Wingrove, 1997, Molecular pharmacology.

Tracazolate reveals a novel type of allosteric interaction with recombinant gamma-aminobutyric acid(A) receptors.

P. Whiting, K. Wafford, L. Connelly, 2002, Molecular pharmacology.